Shop by goal

  • Fat Loss
  • Growth Hormone
  • Muscle Growth
  • Tissue Repair
  • Recovery
  • Anti-Aging
  • Cognitive
  • Accessories
  • All compounds →
  • Popular compounds

  • BPC-157
  • TB-500
  • GHK-Cu
  • Retatrutide
  • Tirzepatide
  • Semaglutide
  • All bestsellers →
  • Research resources

  • Certificates of Analysis
  • Compare Compounds
  • Peptide Guides
  • Delivery Guide
  • Track Order
  • Recently viewed

  • All peptide guides
  • Crypto Blog
  • How to Reconstitute
  • Reconstitution Calculator
  • How to Store
  • Protocols
  • Certificates of Analysis
  • Sign In
  • Create Account
  • My Account
  • My Orders
  • My Referrals
  • Log Out
  • Track Order
  • Refer a Friend
  • Follow us on Twitter/X
  • How-to guides

    CJC-1295 (with DAC): HGH / Somatropin research guide

    Not medical advice. CJC-1295 (with DAC) is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

    What CJC-1295 (with DAC) is

    CJC-1295 with DAC is a long-acting GHRH analog that covalently bonds to serum albumin, extending its functional half-life from minutes to roughly 6-8 days for weekly GH research protocols.

    One-paragraph overview from our research datasheet — still scientific, but faster to read than the full mechanism list below.

    CJC-1295 DAC, long-acting GHRH analogue with maleimidopropionic acid Drug Affinity Complex enabling covalent albumin binding and 6–8 day half-life.

    Research contexts

    Peer-reviewed literature typically discusses CJC-1295 (with DAC) in specific experimental settings. The points below reflect how the scientific community frames this compound—not as health claims, but as the research questions being asked.

    Research vs. personal use: Literature describes experiments in controlled lab and animal models. This is distinct from any real-world use; our products are for laboratory research only.

    Typical study contexts

  • Pituitary GH release patterns, receptor signalling, and metabolic readouts in compliant animal research.
  • Comparisons between secretagogues and exogenous GH in model organisms, focusing on endocrine biology.
  • Peer-reviewed preclinical work sometimes describes experiments that track whether covalent albumin bioconjugation via MPA-Cys34 bond extends half-life to 5.8–8.1 days
  • Peer-reviewed preclinical work sometimes describes experiments that track whether tetrasubstituted GHRH(1-29) backbone confers complete DPP-IV protease resistance
  • Peer-reviewed preclinical work sometimes describes experiments that track whether produces sustained dose-dependent GH elevation of 2–10-fold for 6+ days per injection
  • Peer-reviewed preclinical work sometimes describes experiments that track whether elevates IGF-1 levels 1.5–3-fold with accumulative effect over 9–28 days
  • Why HGH / Somatropin research matters

    Growth-hormone axis peptides are researched for how they signal through the GH/IGF pathway in animals and cells. Studies focus on endocrine biology and metabolism, not on prescribing or outcomes in people.

    Mechanisms (technical review)

    Our datasheet lists mechanistic themes observed in preclinical work. These are research endpoints, not health claims. They help scientists understand and compare pathways.

  • Covalent albumin bioconjugation via MPA-Cys34 bond extends half-life to 5.8–8.1 days
  • Tetrasubstituted GHRH(1-29) backbone confers complete DPP-IV protease resistance
  • Produces sustained dose-dependent GH elevation of 2–10-fold for 6+ days per injection
  • Elevates IGF-1 levels 1.5–3-fold with accumulative effect over 9–28 days
  • Maintains GHRH receptor-mediated pulsatile GH release pattern preserving somatostatin feedback
  • Approximately 700-fold half-life extension versus native GHRH enabling weekly dosing protocols
  • Lab handling & preparation

    Storage requirements: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation. · Learn best practices in our detailed storage guide.

    Research dosing context: Literature typically discusses 1–2 mg subcutaneously · Once or twice weekly due to extended 6–8 day half-life · Terminal t½ = 5.8–8.1 days; albumin bioconjugation occurs within 15 min post-injection; GH elevation persists ≥6 days; IGF-1 elevation persists 9–11 days after single dose; steady-state IGF-1 with repeated dosing at 28 days. No-DAC variant has ~30 min half-life for comparison.

    Preparation steps: Follow our detailed reconstitution guide, use the calculator tool for volume confirmation, and always verify purity with the COA reading guide.

    Common Questions People Are Asking

    What is CJC-1295?

    CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH 1-29) with four amino-acid substitutions that resist enzymatic breakdown. It activates the pituitary GHRH receptor to drive growth-hormone release. This DAC version adds a "Drug Affinity Complex" tag that binds serum albumin, extending its half-life to ~6-8 days. Supplied as a lyophilised research-grade powder for laboratory use only.

    What does CJC-1295 do?

    In research models CJC-1295 binds the GHRH receptor on the pituitary and stimulates the release of growth hormone, which in turn raises IGF-1. The DAC tag sustains that signal for days rather than minutes. These are findings in cell and animal models; no human therapeutic effect is implied.

    Is CJC-1295 safe?

    In published animal studies CJC-1295 has generally been well tolerated, but there are no controlled human safety trials, so human safety is not established. It is a research compound, not a medicine; New-U makes no human-use claims and supplies it for laboratory research only.

    Is CJC-1295 FDA approved?

    No. CJC-1295 is an investigational research peptide and is not approved by the FDA, EMA, or any other regulator for human therapeutic use. It is sold strictly for preclinical and in-vitro research.

    What does "DAC" actually mean?

    DAC stands for "Drug Affinity Complex". It is a small chemistry tag - specifically maleimidopropionic acid - attached to the C-terminal lysine of the peptide. When you inject the peptide, the DAC reacts with the free thiol of cysteine-34 on serum albumin, forming a covalent bond. The peptide then piggy-backs on albumin for days.

    How is CJC-1295 DAC different from the no-DAC version?

    Both share the same tetrasubstituted GHRH(1-29) backbone. The DAC version carries the albumin-binding tag and lasts ~6-8 days; the no-DAC version (often called Modified GRF 1-29) has no DAC tag and lasts roughly 30 minutes. DAC is used for sustained elevation; no-DAC is used for physiologic pulses.

    Which is better - CJC-1295 DAC or no-DAC?

    Neither is universally "better" - they answer different research questions. The DAC form gives sustained, days-long GH/IGF-1 elevation from a single dose and is studied on roughly weekly schedules thanks to its 6-8 day half-life. The no-DAC form (Modified GRF 1-29) produces short, natural-shaped GH pulses and is studied with more frequent dosing. The choice depends on whether a study needs continuous elevation or pulsatile signalling. Both are research-use-only materials, not approved medicines.

    Why combine CJC-1295 with ipamorelin?

    GHRH analogs like CJC-1295 and ghrelin-receptor agonists like ipamorelin hit two different receptors (GHRHR and GHSR) that synergise in GH release. Combining them produces larger, cleaner GH pulses than either peptide alone, which is why this is a standard research pairing.

    How should CJC-1295 DAC be stored?

    Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water, refrigerate at 1-6 °C and protect from light. The DAC chemistry is relatively stable once the peptide is in solution, but plan dosing to use reconstituted material within the standard peptide-stability window.

    What happens if you stop taking peptides?

    CJC-1295 is a GHRH analogue that stimulates the pituitary's own GH release rather than replacing a hormone. In the research literature, ending administration returns the GH/IGF-1 axis toward its untreated baseline; the DAC form's albumin binding means it clears over a week or more, so the stimulus tapers gradually rather than stopping instantly. Unlike exogenous HGH, no axis-shutdown rebound is described. These are research-model observations — CJC-1295 DAC is supplied for laboratory research only and is not for human use.

    Is this page medical advice? Can I use CJC-1295 (with DAC) for my health?

    No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

    Where do I find CJC-1295 (with DAC) specs, purity certificates and pricing?

    Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

    Related peptide guides

    Other compounds researchers often read about alongside CJC-1295 (with DAC).

  • HGH 191 AA - companion guide
  • Tesamorelin - companion guide
  • Sermorelin - companion guide
  • HGH Fragment 176-191 - companion guide
  • Scientific sources & further reading

    Primary literature and registries for CJC-1295 (with DAC), plus mainstream coverage of the peptide category. Research use only - not medical advice.

    Databases & literature:

  • PubMed: peer-reviewed literature on CJC-1295
  • ClinicalTrials.gov: registered studies on CJC-1295
  • CJC-1295: Wikipedia
  • Peptides in the news:

  • WebMD: consumer health reference
  • BBC News: Health
  • CNN Health: “Peptides: what to know about the wellness trend”
  • Sky News: “Can peptides make America healthy again?”
  • Sky News: “Inside the exploding US peptides craze” (video)
  • Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”
  • Sky News Australia: “Backyard peptide boom sparks alarm” (video)
  • Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”
  • Ready to order? View full product specs

    Access concentration, batch info, variants, and current pricing on our shop.

    Also known as: CJC-1295 with DAC, DAC:GRF, Drug Affinity Complex GRF, CJC-1295 DAC, Modified GRF 1-29 with DAC, ConjuChem GRF

    Premium research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical with a Certificate of Analysis on every lot. Shipped lab-direct, discreet and cold-chain, worldwide. For laboratory research use only.

    Shop

  • All Peptides
  • Fat-Loss Peptides
  • Skin & Anti-Aging
  • Stacks & Protocols
  • Compare Vials
  • Peptide 101
  • Learn

  • Research Blog
  • How-To Guides
  • Certificates of Analysis
  • Community Forum
  • Company

  • About Us
  • Contact
  • FAQ
  • Affiliate Program
  • VIP Club
  • Support

  • Shipping & Delivery
  • Pay with Crypto
  • Live Crypto Prices
  • Refund Policy
  • Privacy
  • Terms
  • Ways to Pay

  • Google Pay
  • Apple Pay
  • Venmo
  • PayPal
  • Crypto
  • Cash App
  • Credit Card
  • SEPA
  • Shop by Compound

  • BPC-157
  • TB-500
  • GHK-Cu
  • Tesamorelin
  • Retatrutide
  • Semaglutide
  • Tirzepatide
  • CJC-1295 (without DAC)
  • View all compounds →
  • Shop by Goal

  • Fat Loss
  • Growth Hormone
  • Muscle Growth
  • Tissue Repair
  • Recovery
  • Anti-Aging
  • Cognitive
  • Accessories
  • Ships worldwide

  • United Kingdom
  • Australia
  • Canada
  • Canada (FR)
  • Ireland
  • Malta
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Portugal
  • Greece
  • Austria
  • Poland
  • Sweden
  • Finland
  • Denmark
  • Norway
  • Croatia
  • Slovakia
  • Slovenia
  • Estonia
  • Latvia
  • Lithuania
  • Czechia
  • Hungary
  • Romania
  • Bulgaria
  • Belgium
  • Belgium (FR)
  • Luxembourg
  • USA
  • Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

    All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.

    Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

    © 2026 New-U Research Compounds · new-u.io · @new.u.io

    Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.

    © 2026 New-U Research Compounds · new-u.io — Copyright held with Hilxera Distribution Services LLC. All rights reserved.